STC2 and neoplasm: Conversely, in ER-negative tumors, high STC2 expression may activate alternative stress-response pathways, such as those related to hypoxia, nutrient deprivation, or endoplasmic reticulum stress, which could contribute to a more aggressive tumor phenotype and poorer prognosis.